News

3X4 Genetics and Fullscript's Partnership for Health Innovation

3X4 Genetics and Fullscript's Partnership for Health Innovation

3X4 Genetics & Fullscript Collaboration

3X4 Genetics, a leader in functional nutrigenomics, has announced a significant step forward in its partnership with Fullscript, an integrative medicine platform. This collaboration paves the way for healthcare practitioners to access comprehensive genetic testing and personalized health reports, essential for advancing preventative healthcare.

Empowering Practitioners

Through this innovative partnership, Fullscript's extensive network of healthcare practitioners can harness the insights provided by 3X4 Genetics to gain a deeper understanding of their patients' genetic landscapes. Meanwhile, actionable recommendations derived from this data will enable practitioners to create tailored care plans addressing their patients' unique health challenges.

Enhanced Patient Care

Dr. Jeff Gladd, Chief Medical Officer at Fullscript, expressed enthusiasm about the partnership, stating, "We're excited to collaborate with 3X4 Genetics to integrate their genetic data interpretations into our practitioners' offerings. The 3X4 Blueprint Reports underscore critical areas in genetics and provide actionable recommendations, enriching the quality of whole-person care."

Precision Through Genetic Insights

This partnership aims to enhance the quality of care by allowing practitioners to employ advanced genetic insights from 3X4 Genetics. The Blueprint Reports evaluate 36 metabolic pathways across six essential health domains, including Weight Balance, Heart Health, and Blood Sugar regulation. This comprehensive approach equips patients with knowledge about their nutritional needs, exercise regimes, and lifestyle choices, all personalized based on genetic data.

Unlocking Personalized Care

Dr. Yael Joffe, Chief Science Officer at 3X4 Genetics, highlighted the importance of this accessibility, stating, "Our belief is that understanding genetics can transform care delivery. By making the 3X4 tests accessible through Fullscript, we empower more practitioners with tools to support their patients in achieving long-term wellness outcomes."

About 3X4 Genetics

3X4 Genetics is dedicated to transforming foundational health through advanced genetic testing and nutrigenomic education, supported by a global network of accredited practitioners. Our mission is to help individuals listen to their bodies and make informed health decisions for enhanced longevity and wellbeing.

About Fullscript

Fullscript is at the forefront of redefining whole-person care in the healthcare sector. Since its inception in 2011, Fullscript has provided an integrated platform connecting over 100,000 healthcare providers and ten million patients with personalized health solutions, resulting in remarkable improvements in patient outcomes.

Contact Information

For inquiries, please contact 3X4 Genetics directly through their official website or their provided contact channels.

Frequently Asked Questions

What is the purpose of the partnership between 3X4 Genetics and Fullscript?

The partnership aims to provide healthcare practitioners with improved access to genetic testing and insights, facilitating personalized and preventative healthcare.

Who benefits from the genetic insights provided by this collaboration?

Healthcare practitioners using Fullscript will benefit, as they can offer tailored care plans based on patients' unique genetic profiles.

What types of health areas do 3X4 Genetics' Blueprint Reports cover?

Blueprint Reports analyze key metabolic pathways within crucial health areas such as Weight Balance, Heart Health, and Hormone Health.

Can practitioners order genetic tests directly through Fullscript?

Yes, practitioners can order 3X4 genetic tests directly via the Fullscript platform, streamlining access to genetic insights.

What is the vision of 3X4 Genetics regarding personalized healthcare?

3X4 Genetics envisions unlocking more effective and personalized healthcare solutions through genetic understanding, aiding practitioners in fostering long-term health for patients.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

Perricone MD Launches Innovative Haircare Range Transforming Manageability

Updated Category News Views 205

Perricone MD Unveils Revolutionary Haircare Collection Perricone MD, a trusted name in the skincare industry for over 25 years, is making a significant leap into the haircare sector. This pioneering brand has unveiled a new line designed specifically for mature and damaged hair, harnessing their extensive research and innovative approach to create exceptional haircare...

Continue Reading
Brandywine Realty Trust Reports Strong Q3 Results and Guidance

Updated Category News Views 62

Key Financial Results for Brandywine Realty Trust Brandywine Realty Trust (NYSE: BDN) announced its financial and operating results that have shown considerable progress for the company. In its recent report, it highlighted strong advances in their 2024 business objectives, particularly in achieving and exceeding several key targets. Management Insights Gerard H. Sweeney,...

Continue Reading
SunCar Technology Unveils $30 Million Share Buyback Plan

Updated Category News Views 163

SunCar Technology Group Announces Significant Share Buyback SunCar Technology Group Inc. (NASDAQ: SDA), a leader in innovative cloud-based B2B auto services and auto e-insurance, recently declared an exciting initiative aimed at returning value to its shareholders. The board of directors has authorized a share repurchase program, allowing the company to buy back up to $30...

Continue Reading
Revolutionizing Environmental Safety with Raytron's Technologies

Updated Category News Views 417

Uncovering Climate Challenges with Raytron's Innovation In an age where global environmental concerns are reaching unprecedented levels, Raytron stands out as a beacon of hope. Their innovative thermal imaging technology has the potential to unveil hidden risks that threaten our ecosystem. As we reflect on the legacy of Earth Day, an event that began in 1970, the urgent...

Continue Reading
GPTBots Partners with Vonosis to Transform AI in Southeast Asia

Updated Category News Views 137

GPTBots Forms Strategic Alliance with Vonosis Co., Ltd. HONG KONG — GPTBots.ai, a prominent platform for building enterprise-grade AI agents, has announced a pivotal partnership with Vonosis Co., Ltd., a key player in digital transformations in Thailand. This partnership is set to significantly bolster GPTBots' presence in Southeast Asia, enabling local companies to...

Continue Reading